Trademark Overview
On Saturday, November 16, 2024, a trademark application was filed for AARDVARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AARDVARK THERAPEUTICS trademark a serial number of 98857292. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, November 16, 2024. This trademark is owned by AARDVARK THERAPEUTICS, INC.. The AARDVARK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Therapeutics and clinical programs targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds targeting neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; therapeutic compounds for cancer treatment and management; abuse-deterrent pharmaceutical formulations
Medical and scientific research and development in the field of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, and rare conditions; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions; design and conduct of clinical trials for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, and rare conditions
